Cross-cultural Validation of the COVID-19 Peritraumatic Distress Index (CPDI) Among Spanish and Peruvian Populations

Overview

Journal Sci Rep

Specialty Science

Date 2023 Nov 4

PMID 37923837

Authors

Fabian Bottcher

Bruno Pedraz-Petrozzi

Eva Kathrin Lamade

Maria Pilar Jimenez

Jennifer Rieker

Jose Manuel Reales

Martin Arevalo-Flores

Victor Anculle-Arauco

Hever Kruger-Malpartida

Soledad Ballesteros

Affiliations

Soon will be listed here.

Abstract

The COVID-19 pandemic has had a significant psychological impact worldwide. The COVID-19 Peritraumatic Distress Index (CPDI) is widely used to assess psychological stress during the COVID-19 pandemic. Although CPDI has been validated in Peru and Spain, no cross-cultural validation studies have been conducted. As an exploratory aim, differences in CPDI factorial scores between the most prevalent medical conditions in the two samples (arterial hypertension, respiratory diseases and anxious-depressive disorders) from a general population of Peru and Spain were investigated. We conducted secondary data analysis with data from Peru and Spain to validate the CPDI in a cross-cultural context. Exploratory factor analysis (EFA) and multigroup confirmatory factor analysis (MGCFA) were performed to evaluate the factor structure and measurement invariance of the CPDI across cultural contexts. Concerning the exploratory analysis, we performed a U-Mann-Whitney test to evaluate differences in the factorial scores in the two samples. This study revealed a two-factor solution (stress and rumination/information) for the CPDI that included 21 of the 24 original items, and consistent with previous studies. The MGCFA demonstrated measurement invariance across cultural contexts (scalar invariance), indicating that the CPDI construct has the same meaning across both groups, regardless of cultural context and language variations of Spanish. Patients with anxious-depressive disorders showed higher CPDI factorial scores for both factors, whereas patients with respiratory diseases were only associated with the stress factor. This study provides evidence for the cross-cultural validity of the CPDI, highlighting its utility as a reliable instrument for assessing psychological stress in the context of COVID-19 across different cultures. These findings have important implications for developing and validating measures to assess psychological distress in different cultural contexts.

References

Fegert J, Vitiello B, Plener P, Clemens V . Challenges and burden of the Coronavirus 2019 (COVID-19) pandemic for child and adolescent mental health: a narrative review to highlight clinical and research needs in the acute phase and the long return to normality. Child Adolesc Psychiatry Ment Health. 2020; 14:20. PMC: 7216870. DOI: 10.1186/s13034-020-00329-3. View

Dettmann L, Adams S, Taylor G . Investigating the prevalence of anxiety and depression during the first COVID-19 lockdown in the United Kingdom: Systematic review and meta-analyses. Br J Clin Psychol. 2022; 61(3):757-780. PMC: 9111383. DOI: 10.1111/bjc.12360. View

Arpaci I, Karatas K, Baloglu M . The development and initial tests for the psychometric properties of the COVID-19 Phobia Scale (C19P-S). Pers Individ Dif. 2020; 164:110108. PMC: 7211675. DOI: 10.1016/j.paid.2020.110108. View

Liu S, Heinz A . Cross-Cultural Validity of Psychological Distress Measurement During the Coronavirus Pandemic. Pharmacopsychiatry. 2020; 53(5):237-238. DOI: 10.1055/a-1190-5029. View

Takeuchi E, Katanoda K, Cheli S, Goldzweig G, Tabuchi T . Restrictions on healthcare utilization and psychological distress among patients with diseases potentially vulnerable to COVID-19; the JACSIS 2020 study. Health Psychol Behav Med. 2022; 10(1):229-240. PMC: 8843161. DOI: 10.1080/21642850.2022.2037429. View

Fonseca-Pedrero E, Paino M, Lemos-Giraldez S, Sierra-Baigrie S, Muniz J . Measurement invariance of the Schizotypal Personality Questionnaire-Brief across gender and age. Psychiatry Res. 2011; 190(2-3):309-15. DOI: 10.1016/j.psychres.2011.05.021. View

Nikolova I, Caniels M, Curseu P . COVID-19 Rumination Scale (C-19RS): Initial psychometric evidence in a sample of Dutch employees. Int J Health Plann Manage. 2021; 36(4):1166-1177. PMC: 8251247. DOI: 10.1002/hpm.3165. View

Costantini A, Mazzotti E . Italian validation of CoViD-19 Peritraumatic Distress Index and preliminary data in a sample of general population. Riv Psichiatr. 2020; 55(3):145-151. DOI: 10.1708/3382.33570. View

Caycho-Rodriguez T, Valencia P, Vilca L, Cervigni M, Gallegos M, Martino P . Cross-cultural measurement invariance of the in seven Latin American countries. Death Stud. 2021; 46(8):2003-2017. DOI: 10.1080/07481187.2021.1879318. View

10.

Silva W, Brito T, Pereira C . COVID-19 anxiety scale (CAS): Development and psychometric properties. Curr Psychol. 2020; 41(8):5693-5702. PMC: 7661558. DOI: 10.1007/s12144-020-01195-0. View

11.

Kruger-Malpartida H, Arevalo-Flores M, Anculle-Arauco V, Dancuart-Mendoza M, Pedraz-Petrozzi B . [Medical conditions, symptoms of anxiety, and depression during the COVID-19 pandemic in a population sample of Lima, Peru]. Rev Colomb Psiquiatr. 2022; . PMC: 9135661. DOI: 10.1016/j.rcp.2022.04.004. View

12.

Fountoulakis K, Apostolidou M, Atsiova M, Filippidou A, Florou A, Gousiou D . Self-reported changes in anxiety, depression and suicidality during the COVID-19 lockdown in Greece. J Affect Disord. 2020; 279:624-629. PMC: 7605790. DOI: 10.1016/j.jad.2020.10.061. View

13.

Golechha M . COVID-19, India, lockdown and psychosocial challenges: What next?. Int J Soc Psychiatry. 2020; 66(8):830-832. PMC: 7443955. DOI: 10.1177/0020764020935922. View

14.

Liu S, Heinzel S, Haucke M, Heinz A . Increased Psychological Distress, Loneliness, and Unemployment in the Spread of COVID-19 over 6 Months in Germany. Medicina (Kaunas). 2021; 57(1). PMC: 7827929. DOI: 10.3390/medicina57010053. View

15.

Cao C, Wang L, Fang R, Liu P, Bi Y, Luo S . Anxiety, depression, and PTSD symptoms among high school students in china in response to the COVID-19 pandemic and lockdown. J Affect Disord. 2021; 296:126-129. PMC: 8456154. DOI: 10.1016/j.jad.2021.09.052. View

16.

Dere J, Watters C, Yu S, Bagby R, Ryder A, Harkness K . Cross-cultural examination of measurement invariance of the Beck Depression Inventory-II. Psychol Assess. 2014; 27(1):68-81. DOI: 10.1037/pas0000026. View

17.

de Boer G, Houweling L, Hendriks R, Vercoulen J, Tramper-Stranders G, Braunstahl G . Asthma patients experience increased symptoms of anxiety, depression and fear during the COVID-19 pandemic. Chron Respir Dis. 2021; 18:14799731211029658. PMC: 8261840. DOI: 10.1177/14799731211029658. View

18.

Sawicki A, Zemojtel-Piotrowska M, Balcerowska J, Sawicka M, Piotrowski J, Sedikides C . The fear of COVID-19 scale: Its structure and measurement invariance across 48 countries. Psychol Assess. 2022; 34(3):294-310. DOI: 10.1037/pas0001102. View

19.

Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y . A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychiatr. 2020; 33(2):e100213. PMC: 7061893. DOI: 10.1136/gpsych-2020-100213. View

20.

Putnick D, Bornstein M . Measurement Invariance Conventions and Reporting: The State of the Art and Future Directions for Psychological Research. Dev Rev. 2016; 41:71-90. PMC: 5145197. DOI: 10.1016/j.dr.2016.06.004. View